AMSilk GmbH

Biotechnology, Medical Technology, Nanotechnology, New Materials

  • Short facts

    • Research & Development
  • Year founded 2008
  • 25 Employees (site)
  • Turnover: not available

Products/services: The AMSilk®-Technology enables the production of biopolymers such as spider silk on an industrial scale. These materials are unrivaled by most common synthetic materials. AMSilk addresses many applications and industry sectors with new materials enabling new products with previously unachievable features. Tailor-made materials using the AMSilk®-Technology enable new and superior products with previously unachievable features, spanning multiple industries and applications

Basic data


AMSilk GmbH


Am Klopferspitz 19

PC / City

82152 Planegg


Upper Bavaria


+49 89 5795393-0


not available

Language skills

English, German

Contact person

Management, Research & development: Dr. Lin Römer (Mr.)


Core competencies

AMSilk is the world's first industrial supplier of synthetic silk biopolymers produced by a patented biotechnological process

Key sectors / sub-sectors

  • Biotechnology: Biomaterials
  • Biotechnology: Drug delivery
  • Biotechnology: Tissue engineering and regenerative medicine
  • Medical Technology: Implants, biomaterials, tissue engineering
  • Nanotechnology: Biocompatible materials and layers
  • Nanotechnology: Drug encapsulation, targeted drug delivery
  • New Materials: Fibers and textiles


not available

Sales markets - target industries

not available

Sales markets - target countries

not available

Cooperation offers

not available